International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
about
ALK Signaling and Target Therapy in Anaplastic Large Cell LymphomaSafety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphomaTherapeutic options in peripheral T cell lymphomaNasal NK/T-Cell Lymphoma. A Comparative Analysis of a Mexican Population with the Other Populations of Latin-AmericaRomidepsin for the Treatment of Peripheral T-Cell LymphomaThe aggressive peripheral T-cell lymphomas: 2013Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfallsALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 studyNew molecular insights into peripheral T cell lymphomasPeripheral T and NK cell non-hodgkin lymphoma a challenge for diagnosisIDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.Development of chidamide for peripheral T-cell lymphoma, the first orphan drug approved in ChinaCD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphomaHighly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic ReviewT-cell Lymphoma Epidemiology: the Known and Unknown.Diagnostic, prognostic and therapeutic role of CD30 in lymphoma.Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.T-cell lymphomas, a challenging disease: types, treatments, and future.Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.The Comparative Diagnostic Features of Canine and Human Lymphoma.Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL studyPhase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience.Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma.Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.Romidepsin: in the treatment of T-cell lymphoma.Nodal cytotoxic molecule (CM)-positive Epstein-Barr virus (EBV)-associated peripheral T cell lymphoma (PTCL): a clinicopathological study of 26 cases.Analysis of 142 Northern Chinese patients with peripheral T/NK-Cell lymphomas: subtype distribution, clinicopathologic features, and prognosis.The Plk1 inhibitor BI 2536 in patients with refractory or relapsed non-Hodgkin lymphoma: a phase I, open-label, single dose-escalation study.Pralatrexate: treatment of T-cell non-Hodgkin's lymphoma.Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma.Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma.Panobinostat in lymphoid and myeloid malignancies.A phase I study of everolimus and CHOP in newly diagnosed peripheral T-cell lymphomas.Gamma-delta t-cell lymphomas.Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: a single-institution study of 105 Chinese patients.Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
P2860
Q21129306-5C422AA3-48C1-406E-A351-00DC060ECA1CQ24633761-D60240A5-F744-4046-81CA-37FD885F30C2Q26748857-42BD219F-6A0D-4917-967B-063FC746CE82Q26781684-F2BFF178-3964-4B05-9D0D-994328B10E9CQ26785732-18F945E4-A867-4E7C-B552-2AEFF33911F0Q27003257-782A11C6-F322-4276-9588-A9CCA3DE58A6Q27004241-59424F2E-60D8-4402-B8E9-18D0F50A7F84Q27008898-5E7FBE86-A3F8-464C-9D1A-2E95E98152FDQ27026081-0B65F7BF-EE10-4601-A128-88684B0BEFA0Q27026629-0E4767A3-6841-4B71-8718-192B98D720BDQ27853198-923A64F6-D955-42AD-B9CB-686557D92CE6Q28070073-2BA6EB1E-4290-42F9-ADA6-092D65FC016BQ28235721-EA51A525-72F4-4500-BE77-8D04532C086CQ28554530-0176DC50-B979-4723-9050-12CEF3571924Q30239985-96653DE0-E4F0-4D1F-BCD1-2889AABF75EFQ30240160-EBDDD149-3CA5-4746-81DC-24F0C6C54CF8Q30244110-24DEAAD4-E56E-49E7-86F9-D4CDFEF5AE3FQ30244553-F84E8851-2FA1-49EE-ABA6-F612318505EEQ30275251-9A780183-4725-4F7B-921B-C2E46EA5FF80Q30401307-26907AFD-D9B4-4766-A6F6-66EA54E7BC78Q30613674-95CC4ACF-38CE-4FE1-9EF4-2A406D20FC45Q31092020-A882AA9B-5F03-4B31-B6C8-F73AA33ED184Q33393701-A17C8F48-3DA6-4898-A8A3-3C1FF55018C7Q33394324-289DCD3F-C1D9-445C-97ED-2BEB5F873D04Q33394912-E32246A9-57C3-4AA0-8D72-C11F687F7DAFQ33395423-87375E53-E92A-4B2C-B399-14D227A90597Q33396068-C2104B70-822D-42A3-9DBD-7FD8A9C6BE38Q33396356-B8814834-FD39-499F-A6E7-0F7D8F2691F7Q33396519-1E54D8D7-7CAF-4A3B-9C7F-63A63696AC28Q33401775-9258B26B-76B1-448A-B0E8-D0E3FF7F1BB2Q33402915-C204DCE2-411E-489F-8D73-61B80702D2DFQ33403311-170DF057-99A1-4338-97CD-514916D2827DQ33404897-E72E6305-A64E-4B88-8BBE-A86550315F03Q33405000-DFF9F195-0C0A-456B-B7E9-A588307AD12CQ33405882-953303E7-9F4A-4544-8390-98F6E62C520EQ33408889-B95B90D7-D04B-465C-8A06-A0658AF5D2DDQ33409982-12B898B8-B1AD-49BB-93E5-9AAEDF043976Q33417290-E8FDAFAC-AB40-4B7C-A41A-25E0A5481521Q33417528-83453760-811A-4770-9E42-875782085B4EQ33417976-54CC22ED-0015-4866-9484-1436C70D5EFB
P2860
International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
International peripheral T-cel ...... indings and clinical outcomes.
@ast
International peripheral T-cel ...... indings and clinical outcomes.
@en
International peripheral T-cel ...... indings and clinical outcomes.
@nl
type
label
International peripheral T-cel ...... indings and clinical outcomes.
@ast
International peripheral T-cel ...... indings and clinical outcomes.
@en
International peripheral T-cel ...... indings and clinical outcomes.
@nl
prefLabel
International peripheral T-cel ...... indings and clinical outcomes.
@ast
International peripheral T-cel ...... indings and clinical outcomes.
@en
International peripheral T-cel ...... indings and clinical outcomes.
@nl
P50
P356
P1476
International peripheral T-cel ...... indings and clinical outcomes.
@en
P2093
International T-Cell Lymphoma Project
P304
P356
10.1200/JCO.2008.16.4558
P407
P577
2008-07-14T00:00:00Z